DENALI THERAPEUTICS INC (DNLI)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DNLI
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DNLI | Chief Medical Officer and Head of Development (former) | 52 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RPRX | EVP and President, Lilly Neuroscience; Independent Director | 53 | ["Executive Vice President and President, Lilly Neuroscience since December 2025","Chief Medical Officer and Head of Development of Denali Therapeutics from June 2015 to November 2025","Various roles at Genentech from 2007 to 2015","Associate Medical Director at Johnson & Johnson from November 2006 to October 2007","Instructor in the Department of Neurology and Neurological Sciences at Stanford University from June 2002 to November 2006","Board certified in neurology and psychiatry between 2004 and 2014","M.D. from Cornell University","B.S. in Biochemical Sciences from Harvard College"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| BEAM | Director | 52 | [] | [] | 2025 |